All Stories

  1. Interleukin-36 receptor mediates the crosstalk between plasma cells and synovial fibroblasts
  2. Genomic Responses of Mouse Synovial Fibroblasts During Tumor Necrosis Factor-Driven Arthritogenesis Greatly Mimic Those in Human Rheumatoid Arthritis
  3. Tie2 as a novel key factor of microangiopathy in systemic sclerosis
  4. Epigenetics of the immune system and alterations in inflammation and autoimmunity
  5. Interplay between genetic and epigenetic mechanisms in rheumatoid arthritis
  6. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions
  7. Epigenetics in the pathogenesis of RA
  8. Rheumatoid arthritis: TAK-ing the road to suppress inflammation in synovial fibroblasts
  9. Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis
  10. MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts
  11. AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts
  12. Rheumatoid and Degenerative Arthritis-Associated Inflammation
  13. Micro-RNA in der Pathogenese rheumatischer Erkrankungen
  14. Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts
  15. Correction: Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets
  16. Epigenetics in rheumatoid arthritis
  17. Epigenome Analysis Reveals TBX5 as a Novel Transcription Factor Involved in the Activation of Rheumatoid Arthritis Synovial Fibroblasts
  18. Inhibition of Spermidine/Spermine N1-Acetyltransferase Activity: A New Therapeutic Concept in Rheumatoid Arthritis
  19. SIRT6 regulates the cigarette smoke-induced signalling in rheumatoid arthritis synovial fibroblasts
  20. Emerging role of extracellular vesicles in inflammatory diseases
  21. Smoking induces transcription of the heat shock protein system in the joints
  22. Epigenetics in rheumatic diseases
  23. The epigenome of synovial fibroblasts: an underestimated therapeutic target in rheumatoid arthritis
  24. Dual Role of Autophagy in Stress-Induced Cell Death in Rheumatoid Arthritis Synovial Fibroblasts
  25. Epigenetics
  26. Epigenetics
  27. Levels of target activation predict antifibrotic responses to tyrosine kinase inhibitors
  28. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
  29. BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatment
  30. Taux sériques de BAFF chez les patients atteints de spondylarthrite ankylosante et traités par anti-TNF
  31. Epigenetic modifications in rheumatoid arthritis, a review
  32. Faculty of 1000 evaluation for Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury.
  33. Tumor Necrosis Factor α-Induced MicroRNA-18a Activates Rheumatoid Arthritis Synovial Fibroblasts Through a Feedback Loop in NF-κB Signaling
  34. Epigenetics
  35. MicroRNAs in Rheumatoid Arthritis
  36. Increased recycling of polyamines is associated with global DNA hypomethylation in rheumatoid arthritis synovial fibroblasts
  37. Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance
  38. ATP Induced Brain-Derived Neurotrophic Factor Expression and Release from Osteoarthritis Synovial Fibroblasts Is Mediated by Purinergic Receptor P2X4
  39. The pattern-recognition receptor nucleotide-binding oligomerization domain-containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts
  40. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis
  41. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension
  42. Innate Mechanisms of Synovitis – Fibrin Deposits Contribute to Invasion
  43. A comparison of data quality control protocols for atmospheric mercury speciation measurements
  44. Future direction of pathogenesis and treatment for rheumatic disorders
  45. Epigenetic contributions in the development of rheumatoid arthritis
  46. Smoking induces expression of ligands of the immune receptor NKG2D
  47. MiRs in RA: possible biomarkers and therapeutic targets
  48. Immune cell - derived microparticles contribute to the resistance of rheumatoid arthritis synovial fibroblasts to death receptor-mediated apoptosis
  49. Cigarette smoke downregulates HDAC2 in rheumatoid arthritis synovial fibroblasts
  50. Stand der Gentherapie bei Rheumatoid Arthritis
  51. Epigenetic Epidemiology of Inflammation and Rheumatoid Arthritis
  52. Inflammatory memories: Is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis?
  53. Epigenetic modifications: novel therapeutic strategies for systemic sclerosis?
  54. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation
  55. Epigenetic Deregulation in Rheumatoid Arthritis
  56. The Role of Epigenetics in Immune Disorders
  57. MicroRNAs as new player in rheumatoid arthritis
  58. Rheumatoid arthritis progression mediated by activated synovial fibroblasts
  59. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis
  60. Epigenetics and rheumatoid arthritis: The role of SENP1 in the regulation of MMP-1 expression
  61. Trex-1 deficiency in rheumatoid arthritis synovial fibroblasts
  62. What can we learn from epigenetics in the year 2009?
  63. TLRs and chronic inflammation
  64. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis
  65. Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts
  66. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts
  67. Prospective new biological therapies for rheumatoid arthritis
  68. Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast–dependent osteoclastogenesis
  69. Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis
  70. The role of resistin as a regulator of inflammation: Implications for various human pathologies
  71. Epigenetics in Rheumatoid Arthritis
  72. The small ubiquitin-like modifier mediates the resistance of prosthesis-loosening fibroblast-like synoviocytes against fas-induced apoptosis
  73. Caveolin-1 Expression and Hemodynamics in COPD Patients
  74. Epigenetic control in rheumatoid arthritis synovial fibroblasts
  75. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis
  76. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts
  77. Fibroblasts and Fibroblast-like Synoviocytes
  78. Toll-Like Receptors and Rheumatoid Arthritis
  79. Targeting the epigenetic modifications of synovial cells
  80. Synovial Fibroblasts: Important Players in the Induction of Inflammation and Joint Destruction
  81. Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis
  82. Mechanisms of vascular damage in systemic sclerosis
  83. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis
  84. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis
  85. The controversial role of tumor necrosis factor α in fibrotic diseases
  86. Changes in the Surface of the Mouse Blastocyst at Implantation
  87. Is there a future for small molecule drugs in the treatment of rheumatic diseases?
  88. The role of resident synovial cells in destructive arthritis
  89. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis
  90. Epigenetic clues to rheumatoid arthritis
  91. Molekulare Signalwege der aseptischen Endoprothesenlockerung / Molecular pathways in aseptic loosening of orthopaedic endoprosthesis
  92. Epigenetic modifications in rheumatoid arthritis
  93. DREAM is reduced in synovial fibroblasts of patients with chronic arthritic pain: is it a suitable target for peripheral pain management?
  94. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis
  95. Matrix metalloproteinases
  96. Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis
  97. Up‐regulation of δ‐opioid receptors and κ‐opioid receptors in the skin of fibromyalgia patients
  98. Emerging targets of biologic therapies for rheumatoid arthritis
  99. Mechanisms of Disease: molecular insights into aseptic loosening of orthopedic implants
  100. In Situ Hybridization of Synovial Tissue
  101. Subtractive Hybridization
  102. Genotyping of Synovial Fibroblasts
  103. Epigenetics in inflammatory rheumatic diseases
  104. Proteinases in the joint: clinical relevance of proteinases in joint destruction
  105. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts
  106. Gene Transfer to Synovial Fibroblast
  107. Laser Capture as a Tool for Analysis of Gene Expression in Inflamed Synovium
  108. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis
  109. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients
  110. Pre–B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities
  111. The role of membrane lipids in the induction of macrophage apoptosis by microparticles
  112. Molecular and cellular basis of rheumatoid joint destruction
  113. Synovial Activation in Rheumatoid Arthritis
  114. Synovial cell activation
  115. Introduction
  116. Technology Insight: gene transfer and the design of novel treatments for rheumatoid arthritis
  117. High Resolution Molecular Analysis as Tool for Evaluation of Arthritis Pathology
  118. The DREAM of Pain Relief
  119. High-resolution molecular analysis for research in rheumatology
  120. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis
  121. S100A4 (Mts1): Is there any relation to the pathogenesis of rheumatoid arthritis?
  122. Genetic Markers of Joint Disease
  123. Spondylarthritides and related entities: Entheses and hypotheses
  124. Microparticles as mediators of cellular cross-talk in inflammatory disease
  125. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
  126. Detection of kappa and delta opioid receptors in skin—Outside the nervous system
  127. Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis
  128. Synovial fibroblasts in joint destruction of rheumatoid arthritis
  129. Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis
  130. Nucleofection: a new, highly efficient transfection method for primary human keratinocytes*
  131. The Role of Synovial Fibroblasts in Mediating Joint Destruction in Rheumatoid Arthritis
  132. The role of Toll-like receptor signalling in the pathogenesis of arthritis
  133. Gene analysis for exploring the effects of drugs in rheumatoid arthritis
  134. The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: New insights from animal models
  135. Deficient expression of interleukin-10 receptor α chain in rheumatoid arthritis synovium: Limitation of animal models of inflammation
  136. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll-like receptor 3
  137. Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: An imbalance between proinflammatory and antiinflammatory lipid mediators
  138. Gene transfer to design novel treatments for rheumatoid arthritis
  139. Detection of Synovial Macrophages in an Experimental Rabbit Model of Antigen-induced Arthritis: Ultrasmall Superparamagnetic Iron Oxide–enhanced MR Imaging
  140. Gene targeting: Roadmap to future therapies
  141. Pattern recognition receptors and their involvement in the pathogenesis of arthritis
  142. Functional genomics of fibroblasts
  143. The L1 Retroelement-related p40 Protein Induces p38δ MAP Kinase
  144. Toll-like receptors direct antimicrobial immune responses— and driving arthritis?
  145. Modulation of pathways regulating both the invasiveness and apoptosis in rheumatoid arthritis synovial fibroblasts
  146. Expression and localization of opioid receptors in muscle satellite cells: no difference between fibromyalgia patients and healthy subjects
  147. Galectin 3 and its binding protein in rheumatoid arthritis
  148. The SCID mouse model: novel therapeutic targets ? lessons from gene transfer
  149. Neues Buch: Rheumatische Erkrankungen und Entzündung von Stefan Laufer, Steffen Gay und Kay Brune
  150. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: Destructive potential in vitro and in vivo
  151. Induction of p16 at sites of cartilage invasion in the SCID mouse coimplantation model of rheumatoid arthritis
  152. Gene transfer as a future therapy for rheumatoid arthritis
  153. Elevated levels of leukotriene B4 and leukotriene E4 in bronchoalveolar lavage fluid from patients with scleroderma lung disease
  154. Apoptosis in rheumatoid arthritis
  155. Cartilage Destruction Mediated by Synovial Fibroblasts Does Not Depend on Proliferation in Rheumatoid Arthritis
  156. Carol-Nachmann-Preis 2003 der Stadt Wiesbaden f�r Prof. A. Robin Poole, Montreal, Canada
  157. Neue Werkzeuge zur molekularen Analyse der Arthrose
  158. Expression and Regulation of Toll-Like Receptor 2 in Rheumatoid Arthritis Synovium
  159. Reply
  160. Minimum information about a microarray experiment: Comment on the editorial by Firestein and Pisetsky
  161. Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling
  162. Möglichkeiten der Gentherapie
  163. Molekularmedizinische Grundlagen von rheumatischen Erkrankungen
  164. Immunogenetik der Arthritis
  165. Gene transfer as a future therapy for rheumatoid arthritis
  166. Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis
  167. Reply
  168. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis
  169. Reply
  170. Role of nuclear factor κb in synovial inflammation
  171. THE MOLECULAR CONTROL OF ANGIOGENESIS
  172. Modern Therapeutics in Rheumatic Diseases
  173. Designing novel therapeutic strategies for rheumatic diseases
  174. Detection of mRNA by non-radioactive direct primed in situ reverse transcription
  175. Rheumatoid arthritis
  176. Development and characteristics of a synovial‐like interface membrane around cemented tibial hemiarthroplasties in a novel rat model of aseptic prosthesis loosening
  177. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion
  178. Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion
  179. Development and characteristics of a synovial-like interface membrane around cemented tibial hemiarthroplasties in a novel rat model of aseptic prosthesis loosening
  180. Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis
  181. Gene transfer of protective cytokines in rheumatoid arthritis
  182. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: Association with genomic DNA hypomethylation and influence on gene expression
  183. Expression of osteoclast differentiation factor in rheumatoid arthritis
  184. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis
  185. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts
  186. Differential expression pattern of membrane‐type matrix metalloproteinases in rheumatoid arthritis
  187. Activation of synoviocytes
  188. Gene transfer: from concept to therapy
  189. Rheumatoid arthritis: editorial overview
  190. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis
  191. Regulation of CS1 Fibronectin Expression and Function by IL-1 in Endothelial Cells
  192. Cartilage erosion in rheumatoid arthritis: studies in SCID mouse model
  193. Rheumatoide Arthritis: Neue molekulare und zelluläre Aspekte
  194. Signaling and effector pathways
  195. Rheumatoid arthritis
  196. Anticytokines
  197. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis
  198. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model
  199. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis
  200. Do antivirals have any utility in the treatment of arthritis?
  201. Gene therapy in osteoarticular diseases: where are we?
  202. Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis
  203. Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue
  204. Retrovirus-associated rheumatic syndromes
  205. Rheumatoid arthritis
  206. Molecular biology of cartilage and bone destruction
  207. T cell-independent joint destruction
  208. Retroviral Sequences in Rheumatoid Arthritis Synovium
  209. T cell-independent joint destruction
  210. Cellular pathways of joint destruction
  211. Cysteine proteinases in arthritis and inflammation
  212. Rheumatoid arthritis
  213. Molecular basis of rheumatoid joint destruction: analogies to the pathogenesis of autoimmunity in diabetes
  214. Progressive joint destruction in a human immunodeficiency virus-infected patient with rheumatoid arthritis
  215. Comparative analysis of cathepsin l, cathepsin d, and collagenase messenger rna expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization
  216. Expression of e-selectin messenger RNA and protein in rheumatoid arthritis
  217. Rheumatoid arthritis Editorial overview
  218. Enzymatic detection systems for non-isotopic in situ hybridization using biotinylated cDNA probes
  219. Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis
  220. Spontaneous Arthritis Models
  221. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into scid mice
  222. Oncogenes, growth factors, and matrix in the pathogenesis of systemic sclerosis
  223. Interactions of syndecan-1 and heparin with human collagens
  224. Cytokines and oncogenes in cellular interactions of rheumatoid arthritis
  225. Molecular and Cellular Basis of Matrix Destruction and Repair in Periodontal Disease
  226. Letter from the Editors-in-Chief
  227. Binding of serum immunoglobulins to collagens in IgA nephropathy and HIV infection
  228. Oncogene activation in rheumatoid synovium
  229. Growth factors, extracellular matrix, and oncogenes in scleroderma
  230. Expression of collagenase and potential transcriptional factors in the MRL/1 mouse arthropathy
  231. Collagen autoantibodies in patients with vasculitis and systemic lupus erythematosus
  232. Detection of p24 in HIV-1 infected cells embedded in LR White and Lowicryl K4M
  233. Immunolocalization of Types V and XI Collagen in Cartilage Using Monoclonal Antibodies
  234. Expression of the Collagenolytic and Ras-Induced Cysteine Proteinase Cathepsin L and Proliferation-Associated Oncogenes in Synovial Cells of MRL/I Mice and Patients with Rheumatoid Arthritis
  235. Intracellular Secretory Pathway and Ultrastructural Localization of Interstitial Procollagenase in Human Gingival Fibroblasts
  236. Collagen profile in the transplanted heart
  237. Molekulare Basis und Onkogenexpression bei der rheumatischen Gelenkzerstörung
  238. Immunohistologic demonstration of type ii collagen in synovial fluid phagocytes of osteoarthritis and rheumatoid arthritis patients
  239. Immunopathology of rheumatoid arthritis
  240. The extracellular matrix in large-cell lymphomas: A histopathologic, immunohistochemical, and ultrastructural study
  241. Immunohistologic Demonstration of Platelet-derived Growth Factor (PDGF) and sis-Oncogene Expression in Scleroderma
  242. The Collagens
  243. The Hemopoietic Extracellular Matrix
  244. Evidence for Multiple Functions of T-Lymphocytes Associated Serine Proteinases
  245. Editorial
  246. Collagens support embryo attachment and outgrowth in vitro: Effects of the Arg-Gly-Asp sequence
  247. Book ReviewThe Synovial Lining in Health and Disease
  248. Collagen content and types in the intestinal strictures of Crohn's disease
  249. Characterization and isolation of poly- and monoclonal antibodies against collagen for use in immunohistochemistry
  250. The extracellular matrix in “Sclerosing” follicular center cell lymphomas: An immunohistochemical and ultrastructural study
  251. LDA-1: A Ubiquitous Noncollagenous Lamina Densa Component of Basement Membrane Detected by Monoclonal Antibody Technique
  252. Localization of Type V Collagen with Monoclonal Antibodies in Developing Dental and Peridental Tissues of the Rat and Hamster
  253. Immunolocalization of γ-Carboxyglutamic Acid Containing Proteins in Developing Rat Bones
  254. Morphological studies of the epiphyseal growth zone in the brachymorphic (bm/bm) mouse
  255. Aspirin causes in vivo synthesis of type i collagen by atrophic articular cartilage
  256. Histological and immunohistological identification of collagens in basement membranes of Schwann cells of neurofibromas
  257. Overview: What Is Collagen, What Is Not
  258. Editorial
  259. [1] Collagen: An overview
  260. The Collagenous Exocytoskeleton of Smooth Muscle Cells
  261. Editorial
  262. Collagen molecules comprised of α1(V)-chains (B-chains): an apparent localization in the exocytoskeleton
  263. Autoantibodies to Basement Membrane Collagen: Epidermolysis Bullosa Simplex versus Bullous Pemphigoid
  264. The collagens of the joint
  265. Immunoelectron Microscopy of Type III Collagen in Normal and Scleroderma Skin
  266. Association of collagen with preimplantation and peri-implantation mouse embryos
  267. Collagen types synthesized in dermal fibroblast cultures from patients with early progressive systemic sclerosis
  268. Scleroderma
  269. Antibodies to distinct types of collagens and procollagens and their application in immunohistology
  270. Dermal architecture and collagen type distribution
  271. Study of differential collagen synthesis during development of the chick embryo by immunofluorescence
  272. Study of differential collagen synthesis during development of the chick embryo by immunofluorescence
  273. Chondrocytes in Aging Research
  274. Subtractive Hybridization
  275. Gene Therapy Approaches for Rheumatoid Arthritis
  276. In Situ Hybridization of Synovial Tissue
  277. Genotyping of Synovial Fibroblasts: cDNA Array in Combination with RAP-PCR in Arthritis
  278. Laser Capture as a Tool for Analysis of Gene Expression in Inflamed Synovium
  279. Gene Transfer to Synovial Fibroblast: Methods and Evaluation in the SCID Mouse Model
  280. Gene Targeting of Cytokines and the Mitogen-Activated Protein Kinase Pathways in Human Rheumatoid Synovium Using the Severe Combined Immunodeficiency Mouse Model